Streetbeat News

Stock Prices

ADEA

Adeia (NASDAQ:ADEA) reported Q4 earnings with an EPS of $0.27, beating estimates by 8.0% but with a revenue decrease of $16.42 million from the previous year. The company has a history of surpassing EPS estimates, which previously led to a share price increase.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 9:15 pm

VNOM

Viper Energy (NASDAQ:VNOM) reported Q4 earnings with an EPS of $0.67, beating estimates by 17.54% and showing a revenue increase of $1.09 million from the previous year. The company has a history of surpassing EPS estimates, leading to share price increases.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 9:15 pm

HD

Home Depot, Inc (NYSE:HD) reported mixed Q4 fiscal 2023 results with an EPS of $2.82, surpassing estimates but with a 2.9% Y/Y decrease in net sales to $34.8 billion. Comparable sales also fell by 3.5% Y/Y. The company's operating margin decreased to 11.9%. For fiscal 2024, Home Depot provided cautious guidance, including a 1.0% sales growth and a 1.0% decline in comparable sales, both below consensus estimates. Goldman Sachs analyst Kate McShane reiterated a Buy rating on HD with a $393 price target, expecting an adverse reaction to the guidance.

Portfolio Pulse from Anusuya Lahiri

February 20, 2024 | 9:14 pm

BTMD

Biote Corp. (NASDAQ:BTMD) has reached an agreement to resolve litigation with its founder, Dr. Gary S. Donovitz, by repurchasing approximately 18.4 million of its Class A shares and Paired Interests from Donovitz at $4.17 per share, totaling about $76.9 million. This settlement includes a mutual release of all claims, termination of the founder advisory agreement, and a two-year non-compete and non-solicitation agreement with Donovitz. The repurchase is supported by Biote's strong capital position and is expected to be accretive to shareholder value.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:14 pm

TDOC

Teladoc forecasts its FY24 earnings per share (EPS) to be between ($1.10) and ($0.80), which is an improvement over the estimated $(1.23). However, its revenue projection of $2.635B to $2.735B falls short of the estimated $2.77B.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:13 pm

MATX

Matson (NYSE:MATX) reported Q4 2023 earnings of $1.78 per share, surpassing the $1.30 estimate by 36.92%. Quarterly sales reached $788.90M, exceeding the $733.60M estimate by 7.54%, yet marking a 1.58% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:11 pm

CZR

Caesars Entertainment (NASDAQ:CZR) reported Q4 earnings, beating estimates with an EPS of $0.1 against an expected -$0.04. Revenue increased by $4.00 million from the previous year. Despite beating last quarter's EPS estimate, the share price dropped by 1.05% the following day. Historical earnings data shows fluctuating performance over the past year.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 9:11 pm

CHK

Chesapeake Energy (NASDAQ:CHK) reported Q4 earnings with an EPS of $1.31, surpassing the estimate of $0.75 by 74.67%. However, revenue decreased by $2.18 billion from the same period last year. In the previous quarter, CHK beat the EPS estimate by $0.45, leading to a 0.96% increase in share price the following day. The company has shown a pattern of surpassing EPS estimates over the past four quarters.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 9:10 pm

THAR

Tharimmune Inc (NASDAQ:THAR) completed its Phase 1 clinical trial for TH104, a transmucosal buccal film for chronic liver disease, showing safety and tolerability comparable to FDA-approved nalmefene. The trial's full data is expected in Q2 2024. Last quarter, Tharimmune closed an $11 million public offering to extend its cash runway into early 2025 for TH104's clinical readouts. THAR shares rose 0.26% to $0.39.

Portfolio Pulse from Vandana Singh

February 20, 2024 | 9:10 pm

WSC

WillScot Mobile Mini (NASDAQ:WSC) reported Q4 earnings with an EPS of $0.44, missing estimates by 15.38% against an expected $0.52. Revenue increased by $21.82 million from the previous year. The company's past earnings performance shows a mixed trend with occasional beats and misses. Last quarter, a slight beat in EPS was followed by an 8.77% drop in share price the next day.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 9:10 pm